IRIS
MARTORANA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.028
AS - Asia 2.076
EU - Europa 2.064
SA - Sud America 262
AF - Africa 234
Continente sconosciuto - Info sul continente non disponibili 104
OC - Oceania 3
Totale 7.771
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.935
SG - Singapore 835
IT - Italia 796
RU - Federazione Russa 702
CN - Cina 502
BR - Brasile 214
KR - Corea 176
VN - Vietnam 144
BD - Bangladesh 141
IN - India 115
CI - Costa d'Avorio 112
IE - Irlanda 88
FI - Finlandia 70
FR - Francia 66
SE - Svezia 66
DE - Germania 52
GB - Regno Unito 52
NG - Nigeria 49
NL - Olanda 48
CA - Canada 41
MX - Messico 30
SN - Senegal 29
PL - Polonia 28
IQ - Iraq 24
JP - Giappone 23
AR - Argentina 21
CZ - Repubblica Ceca 20
HK - Hong Kong 20
BJ - Benin 18
ES - Italia 17
BE - Belgio 16
UA - Ucraina 14
ID - Indonesia 13
UZ - Uzbekistan 12
TR - Turchia 11
PK - Pakistan 10
ZA - Sudafrica 10
LT - Lituania 9
IR - Iran 8
AE - Emirati Arabi Uniti 7
PH - Filippine 7
VE - Venezuela 7
AT - Austria 6
JM - Giamaica 6
CO - Colombia 5
CR - Costa Rica 5
IL - Israele 5
AZ - Azerbaigian 4
EC - Ecuador 4
KE - Kenya 4
OM - Oman 4
TN - Tunisia 4
AU - Australia 3
BG - Bulgaria 3
CH - Svizzera 3
MY - Malesia 3
PY - Paraguay 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
CL - Cile 2
DO - Repubblica Dominicana 2
EG - Egitto 2
LB - Libano 2
MA - Marocco 2
MN - Mongolia 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
AI - Anguilla 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
Totale 7.668
Salva come PNG Salva come JPEG
Città #
Dallas 754
Singapore 554
Santa Clara 370
Moscow 329
San Jose 268
Hefei 237
Ashburn 200
Seoul 173
Catania 145
Chicago 140
Los Angeles 125
Chandler 113
Abidjan 112
Council Bluffs 94
Dublin 87
Kochi 80
New York 76
Beijing 66
Lauterbourg 59
Boardman 56
Milan 52
San Giovanni la Punta 47
Palermo 45
Rome 42
Ho Chi Minh City 41
Lappeenranta 37
Hanoi 33
Buffalo 32
Dakar 29
São Paulo 26
Amsterdam 24
Lagos 24
Bari 23
Civitanova Marche 23
Tokyo 23
Warsaw 23
Cambridge 21
Abuja 20
Brno 19
Hong Kong 19
Lawrence 19
Orem 19
Turku 19
Cotonou 18
Munich 18
Naples 17
Brussels 16
Andover 15
Brooklyn 15
Montreal 15
Seattle 14
Chennai 13
Helsinki 13
Phoenix 13
Mexico City 12
Atlanta 11
Florence 11
London 11
Poplar 11
Charlotte 10
Manchester 10
Stockholm 10
Tashkent 10
Wilmington 10
Da Nang 9
Denver 9
Des Moines 9
Johannesburg 9
San Francisco 9
Baghdad 8
Belo Horizonte 8
Bremen 8
Columbus 8
Cosenza 8
Houston 8
Messina 8
Santa Venerina 8
Tehran 8
Aci Catena 7
Frankfurt am Main 7
Grafing 7
Grammichele 7
The Dalles 7
Toronto 7
Haiphong 6
Paternò 6
Pisa 6
Querétaro 6
Ankara 5
Brescia 5
Genoa 5
Jacksonville 5
Philadelphia 5
Port Harcourt 5
San José 5
Washington 5
Belpasso 4
Bologna 4
Boston 4
Campinas 4
Totale 5.210
Salva come PNG Salva come JPEG
Nome #
148P The impact of chemotherapy relative dose intensity on pathological complete response and event-free survival in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy 272
Correlation between weight and Recurrence Score in a cohort of HR+ve/ HER2-ve early breast cancer patients: a retrospective analysis 221
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma 214
Drivers of choice and outcomes of breast-conserving surgery versus mastectomy in breast cancer patients with complete response following neoadjuvant therapy: a retrospective analysis from the EUSOMA database 203
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 197
Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily 185
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 183
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 182
Biomarkers and prognostic factors for malignant pleural mesothelioma 174
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 158
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 157
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 152
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 144
Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells 141
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience 140
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 136
Opportunities and challenges of liquid biopsy in thyroid cancer 133
Orbital metastasis from thyroid cancer: a case report and review of the literature 132
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer 132
ENDOMETRIAL STROMAL TUMOR (SARCOMA) WITH LIMITED MIOMETRIAL INFILTRATION: A RARE CASE WITH PELVI-PERITONEAL METASTASES 132
Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature 130
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 127
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients 126
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 125
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 123
A new kid on the block: Sacituzumab govitecan for the treatment of breast cancer and other solid tumors 122
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far 121
Efficacy of mitomycin C plus a fluoropyrimidine in pretreated patients with metastatic colorectal cancer eligible to regorafenib: Results of a retrospective study 118
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 117
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 117
Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database 111
Farmaci innovativi per il trattamento del carcinoma tiroideo avanzato 110
Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases 110
Implications of antidepressants use in breast cancer: A brief review 108
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype 107
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 104
More Than Meets the Eye: A Case of Breast Cancer Switching from Being Luminal-Androgen-Receptor-Positive to Being Hormone-Receptor-Positive 103
Nasopharyngeal Metastasis from Lung Adenocarcinoma: A Case Report and Literature Review 101
Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer 101
Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer 99
A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors 96
REThinking the role of the RET oncogene in breast cancer 92
Unveiling Prostate-Specific Membrane Antigen’s Potential in Breast Cancer Management 92
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance 90
Can we learn from failures? A systematic review of phase III trials in platinum-resistant ovarian cancer 85
Delayed use of eribulin in a heavily pretreated liposarcoma patient, previously misdiagnosed as leiomyosarcoma 84
Profilo Molecolare in una Coorte di Neoplasie Tiroidee Insorte nell'Area Vulcanica della Sicilia 83
Predictors of mastectomy in breast cancer patients with complete remission of primary tumor after neoadjuvant therapy: A retrospective study 81
Type 2 diabetes and cancer: problems and suggestions for best patient management 80
Bridging the Gap: the role of MDM2 inhibition in overcoming treatment resistance in breast cancer 77
Everything Comes with a Price: The Toxicity Profile of DNA-Damage Response Targeting Agents 76
Efficacy of A Fluoropyrimidine plus Mitomycin C in Pretreated Patients with Metastatic Colorectal Cancer Eligible for Regorafenib: A Retrospective Study 75
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer 74
Correlation between histopathological features and recurrence score according to menopausal status in HR+/HER2– breast cancer patients: a retrospective study 74
Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review 74
Ribociclib efficacy in special populations and analysis of patient reported outcomes in the MONALEESA trials 74
Phase I dose-escalation study of the dual PI3K-mTORC1/2 inhibitor gedatolisib in combination with paclitaxel and carboplatin in patients with advanced solid tumors 74
The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunities 71
Prognostic value of the interval between the last neoadjuvant chemotherapy (CT) administration and breast surgery: Preliminary data of the NeoBracer international observational study 70
Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review 66
Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review 66
A systematic review of phase I trials in patients with ovarian cancer 64
MTClin: Integrating MammaTyper® to predict neoadjuvant therapy response in HER2+ breast cancer 63
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project 60
RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer 59
Letter to the Editor: statistics and clinical perception of patients’ reported outcomes for palbociclib and abemaciclib: a sliding doors story 56
Warming-up the immune cell engagers (ICEs) era in breast cancer: state of the art and future directions 44
Association of neoadjuvant chemotherapy dose intensity with pathological complete response and event-free survival in HER2-negative early breast cancer 39
Reply to: EUSOMA and NCCN should include clinical staging after neoadjuvant therapy as a quality indicator for treatment guidance 37
Radiomics in cervical and endometrial cancer 22
Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review 5
Totale 7.771
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022117 0 14 2 2 21 2 19 3 6 5 12 31
2022/2023429 24 23 21 50 20 60 13 83 85 7 25 18
2023/2024337 43 52 16 12 11 66 3 15 2 19 45 53
2024/20251.617 43 187 81 74 238 224 72 65 67 122 266 178
2025/20264.882 252 455 859 278 642 901 443 87 228 264 311 162
2026/2027302 145 157 0 0 0 0 0 0 0 0 0 0
Totale 7.771